Live feed16:05:00·15dPRReleasevia QuantisnowIMDX Reports Second Quarter 2026 Results and Timely Progress on FDA Review of GraftAssureDxByQuantisnow·Wall Street's wire, on your screen.IMDX· Insight Molecular Diagnostics Inc.BIO· Bio-Rad Laboratories Inc.Health CareIndustrials
